Zymergen
High tech microbes
With unparalleled scale in laboratory automation and computation, Zymergen builds and optimizes the microbes that serve as cellular factories in the $100B+ industrial biotech sector. Zymergen’s products — optimized cellular factories — drop directly into our customers’ existing bio-manufacturing workflows for immediate impact on their bottom line without additional investments in infrastructure and capital equipment.
Zymergen employs Radical Empiricism to design, generate, and optimize microbes by rewriting their DNA. Our approach combines biology, robotic automation, and proprietary computational and analytic methods to industrialize what to date has been a slow, risky, essentially artisanal process. A key element of our success is our ability to apply the latest in Big Data technology and machine learning techniques. As a result, we generate microbes that produce novel chemicals, advanced materials, and pharmaceuticals far faster and at lower costs than competing technology.
Founders
-
Founder @Zymergen, @Norcob Capital • Worked at @McKinsey & Company, @Rothschild • Studied at @Yale, @Berkeley
-
Founder @Zymergen • Worked at @Amyris Biotechnologies, @Stanford School of Medicine • Studied at @Columbia, @UCSF
-
Founder @Zymergen • Worked at @Amyris Biotechnologies • Studied at @Stanford, @Purdue